Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes.
about
Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cellsREV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasisMolecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteinsCharacterization of the rodent genes for arylacetamide deacetylase, a putative microsomal lipase, and evidence for transcriptional regulationHepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1cA role of DNA-PK for the metabolic gene regulation in response to insulinEndocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesityIdentification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoterLiver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesisCentral role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouseRegulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbetaObesity and insulin resistanceOccupancy and function of the -150 sterol regulatory element and -65 E-box in nutritional regulation of the fatty acid synthase gene in living animalsInsig-1 "brakes" lipogenesis in adipocytes and inhibits differentiation of preadipocytesGenetic Variation of Fatty Acid Oxidation and Obesity, A Literature ReviewIs Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress?Pathway-selective insulin resistance and metabolic disease: the importance of nutrient fluxBile acid metabolism and signalingLiver steatosis in hepatitis C patientsThe hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic ratsA century of cholesterol and coronaries: from plaques to genes to statinsTranscriptional regulation of the murine acetyl-CoA synthetase 1 gene through multiple clustered binding sites for sterol regulatory element-binding proteins and a single neighboring site for Sp1Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic isletsSREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevationDistinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1cRole of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistanceProtein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expressionDocosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathwaysKeratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cellsHepatic farnesyl diphosphate synthase expression is suppressed by polyunsaturated fatty acidsInsulin enhances post-translational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesiclesPKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivityDecreased lipid synthesis in livers of mice with disrupted Site-1 protease genePrenatal arsenic exposure alters gene expression in the adult liver to a proinflammatory state contributing to accelerated atherosclerosisSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liverMolecular mediators of hepatic steatosis and liver injuryPolyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes.Glucose regulation of the acetyl-CoA carboxylase promoter PI in rat hepatocytes.Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay.
P2860
Q21142682-BFE81935-D81E-417F-827B-C0695D2A86FFQ21145813-1EFB4C60-CB79-43DB-A3B4-58B965C7E955Q22254257-4BEA1724-6584-4DF6-8F74-385F84D9E2ACQ24291501-3A623586-5BB7-4E0E-859B-30EC0B038E31Q24300790-970D9710-9C42-4676-8AF0-82277CA28FBAQ24323112-4D6F478C-AF89-40B1-A157-5DEEEBA04D6EQ24523292-F49A945D-BC78-4084-892C-81CE0B579B7CQ24550969-CED2442B-E548-4ECB-BD09-111936956E48Q24554492-CB9849BC-A741-4781-9AF9-593879C435ACQ24564225-2B6A73B0-DEA2-4C39-BC31-BFF680D8A02BQ24598068-BF1809D8-BE7C-4DA9-A217-7FCFCB71F5F2Q24607078-609D3B63-5553-42F6-8998-648F12FA6F4BQ24679235-92C44222-B05E-4954-9E76-5E20544B104AQ24681212-159B7DB9-6071-46D7-B502-96C0EA8C1874Q26749062-C36B5B64-F926-49DD-9BCA-70422048EB50Q26769973-BAE51443-0056-47B7-A4FB-3427D83F448FQ26820876-050B092B-16AB-418A-9F3B-A671A9DC4CD3Q27002873-6F01132A-EE40-4196-85EB-E1573752771DQ27010631-1313B9F5-B9A7-4299-A21C-132BD27404A8Q27333171-A3355BBC-ED73-42C8-B52B-C1654974B2B2Q28080618-0228B3F7-2E82-44B6-9342-2054EE35854BQ28204504-FF4B90A0-0C29-48D8-B6AD-E8724307D421Q28268591-10B66734-63C0-4E83-BE0A-0A72F2DEDBCCQ28344493-47AA4FDB-AF46-474C-B4D3-4F0D581D1B90Q28365331-32F914E6-4A08-43BE-8DFE-EC8F16E9E01AQ28513775-765EBAEE-2CBA-4066-9C36-286247BB4C0FQ28568969-88C121C2-420F-479B-AF4C-335DB438159BQ28570423-C731E3B1-9989-4526-872F-06D8194A3BA8Q28576771-EDECDA35-0DA1-41B5-B6B6-E52723CDA8CFQ28580518-A70D9E89-93F6-496C-9D93-AF037FD84FD4Q28581281-7ADB8740-97DB-4D9D-A3B1-19F3CFBCB308Q28581484-994B6B0A-DEEF-43B1-82E8-6E1172E33E3FQ28582308-4FEEFA86-AE50-4798-A167-0D2A66BB8390Q28588943-883D5184-6D4C-4AA5-B555-EA7430DEAD87Q28728378-C6A8449C-0A95-4323-9185-6665EDAE7AC9Q29547646-454962E8-C3CF-42F2-9D43-D25459F23007Q29616709-36FF7C21-21FC-45B2-9AA9-889655CDF19CQ30502199-9AF8620D-4876-4013-9E44-A4E569C0E00AQ30988773-CF1A5C47-D345-4B45-8E13-F8163135DFD0Q31742604-2817AC1F-F9D3-4160-BBD8-799FBE4766D6
P2860
Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Insulin selectively increases ...... reptozotocin-induced diabetes.
@ast
Insulin selectively increases ...... reptozotocin-induced diabetes.
@en
type
label
Insulin selectively increases ...... reptozotocin-induced diabetes.
@ast
Insulin selectively increases ...... reptozotocin-induced diabetes.
@en
prefLabel
Insulin selectively increases ...... reptozotocin-induced diabetes.
@ast
Insulin selectively increases ...... reptozotocin-induced diabetes.
@en
P2093
P2860
P356
P1476
Insulin selectively increases ...... reptozotocin-induced diabetes.
@en
P2093
I Shimomura
J D Horton
J L Goldstein
Y Bashmakov
P2860
P304
13656-13661
P356
10.1073/PNAS.96.24.13656
P407
P577
1999-11-01T00:00:00Z